Cochlear Limited (ASX:COH) has established itself as one of the world's leading medical device companies specialising in implantable hearing technologies. Through decades of research, product development and clinical collaboration, the company has helped expand access to hearing solutions for people with hearing loss across …
CSL Limited (ASX:CSL) is one of Australia's largest healthcare companies and a globally recognised biotechnology business. Through its operations across plasma-derived therapies, vaccines and speciality pharmaceuticals, the company serves patients in more than 100 countries. Continued investment in research, manufacturing and innovation has enabled …
4DMedical Ltd (ASX:4DX) closed on 24 July 2026 at AUD 3.11 after recording a decline of 4.01%, or AUD 0.13, during the latest trading session. The movement came as the broader healthcare sector also faced selling pressure, with the S&P/ASX 200 Health Care (ASX:XHJ) …
PYC Therapeutics Ltd (ASX:PYC) closed trading on 24 July 2026 at AUD 1.66, recording a decline of 0.90% during the session. The company’s share price decreased by AUD 0.015 on the day, while maintaining a positive annual performance, with shares remaining up 28.68% over …
Ramsay Health Care Ltd (ASX:RHC) closed trading on 24 July 2026 at AUD 42.30, recording a marginal decline of 0.07% during the session. The company’s share price decreased by AUD 0.03 on the day, while maintaining positive longer-term performance, with shares remaining up 9.10% …
Mesoblast Ltd (ASX:MSB) traded lower on 24 July 2026, with shares closing at AUD 2.22, representing a decline of 4.31% or AUD 0.100 during the session.
Cochlear Ltd (ASX:COH) closed on 24 July 2026 at AUD 111.61, declining 0.45% or AUD 0.50 during the session. The movement occurred alongside weakness across the broader healthcare sector, with the S&P/ASX 200 Health Care (ASX:XHJ) index trading at 25,198.50 points, down 0.95% today.
Highlights• RGT shares fell 12.28% to AUD 0.05.• Market capitalisation is approximately AUD 5.83 million.• Session turnover was AUD 14,220.• The 12-month return stands at -36.71%, reflecting persistent investor caution.Argent Biopharma Ltd (ASX:RGT) declined 12.28% in the latest session, with shares closing at AUD …
Starpharma Holdings Ltd (ASX:SPL) has delivered one of the more notable one-year share price performances on the ASX, with the stock rising approximately 666.67% over the twelve months to 24 July 2026. The stock traded at AUD 0.69 during the session on 24 July …
4DMedical Ltd (ASX:4DX) has delivered one of the more notable one-year share price performances on the ASX, with the stock rising approximately 1,096.15% over the twelve months to 24 July 2026. The stock traded at AUD 3.11 during the session on 24 July 2026. …